Ralph
26.10.2000, 22:38
.... und nicht zu knapp, über 10% :(
******************************
Inktomi Reports Fourth Quarter and Annual Results
Records Annual Pro Forma Operating Profit Increases Revenues 204% Year over Year
FOSTER CITY, Calif.--(BUSINESS WIRE)--Oct. 26, 2000--Inktomi Corp. (NASDAQ: INKT - news) today reported financial results for the fourth fiscal quarter ended September 30, 2000. Revenues for the quarter totaled $78.6 million, a 190 percent gain over revenues of $27.1 million for the comparable quarter in the last year. Pro forma net income for the quarter, which excludes the amortization of goodwill, employee stock compensation and a one-time charge for purchased in-process research and development, was $8.8 million, or $0.07 per share compared to a net loss of $6.1 million, or a loss of $0.06 per share in the fourth quarter of the previous year.
For the fiscal year also ended September 30, 2000, Inktomi® achieved revenues of $223.5 million, a 204 percent increase over revenues of $73.5 million for the 1999 fiscal year. Pro forma net income for the year was $13.0 million or $0.11 per share compared with a net loss of $29.2 million or a net loss of $0.29 per share in the prior year. Historical results have been restated for acquisitions accounted for under the pooling of interests method.
******************************
Ralph
******************************
Inktomi Reports Fourth Quarter and Annual Results
Records Annual Pro Forma Operating Profit Increases Revenues 204% Year over Year
FOSTER CITY, Calif.--(BUSINESS WIRE)--Oct. 26, 2000--Inktomi Corp. (NASDAQ: INKT - news) today reported financial results for the fourth fiscal quarter ended September 30, 2000. Revenues for the quarter totaled $78.6 million, a 190 percent gain over revenues of $27.1 million for the comparable quarter in the last year. Pro forma net income for the quarter, which excludes the amortization of goodwill, employee stock compensation and a one-time charge for purchased in-process research and development, was $8.8 million, or $0.07 per share compared to a net loss of $6.1 million, or a loss of $0.06 per share in the fourth quarter of the previous year.
For the fiscal year also ended September 30, 2000, Inktomi® achieved revenues of $223.5 million, a 204 percent increase over revenues of $73.5 million for the 1999 fiscal year. Pro forma net income for the year was $13.0 million or $0.11 per share compared with a net loss of $29.2 million or a net loss of $0.29 per share in the prior year. Historical results have been restated for acquisitions accounted for under the pooling of interests method.
******************************
Ralph